BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis
Europe - BIT:1BAYN - DE000BAY0017 - Common Stock
27.285 EUR
-0.64 (-2.29%)
1BAYN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 54 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of 1BAYN have multiple concerns. 1BAYN is valued quite cheap, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
1BAYN had positive earnings in the past year.
In the past year 1BAYN had a positive cash flow from operations.
In multiple years 1BAYN reported negative net income over the last 5 years.
Each year in the past 5 years 1BAYN had a positive operating cash flow.
1.2 Ratios
The Return On Assets of 1BAYN (-3.25%) is worse than 64.81% of its industry peers.
Looking at the Return On Equity, with a value of -11.25%, 1BAYN is doing worse than 64.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROIC | N/A |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
1BAYN's Operating Margin has declined in the last couple of years.
1BAYN has a Gross Margin of 54.95%. This is in the lower half of the industry: 1BAYN underperforms 68.52% of its industry peers.
1BAYN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for 1BAYN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% |
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
2. Health
2.1 Basic Checks
1BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, 1BAYN has about the same amount of shares outstanding.
The number of shares outstanding for 1BAYN remains at a similar level compared to 5 years ago.
The debt/assets ratio for 1BAYN has been reduced compared to a year ago.
2.2 Solvency
1BAYN has an Altman-Z score of 0.78. This is a bad value and indicates that 1BAYN is not financially healthy and even has some risk of bankruptcy.
1BAYN has a Altman-Z score of 0.78. This is in the lower half of the industry: 1BAYN underperforms 74.07% of its industry peers.
The Debt to FCF ratio of 1BAYN is 8.37, which is on the high side as it means it would take 1BAYN, 8.37 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 8.37, 1BAYN is not doing good in the industry: 64.81% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.04 is on the high side and indicates that 1BAYN has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.04, 1BAYN is doing worse than 64.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Altman-Z | 0.78 |
ROIC/WACCN/A
WACC6.74%
2.3 Liquidity
1BAYN has a Current Ratio of 1.13. This is a normal value and indicates that 1BAYN is financially healthy and should not expect problems in meeting its short term obligations.
1BAYN has a worse Current ratio (1.13) than 66.67% of its industry peers.
A Quick Ratio of 0.73 indicates that 1BAYN may have some problems paying its short term obligations.
1BAYN has a Quick ratio of 0.73. This is in the lower half of the industry: 1BAYN underperforms 72.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
The earnings per share for 1BAYN have decreased strongly by -15.95% in the last year.
Measured over the past years, 1BAYN shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.27% on average per year.
Looking at the last year, 1BAYN shows a decrease in Revenue. The Revenue has decreased by -2.16% in the last year.
1BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-15.95%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-38.78%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-2.09%
3.2 Future
The Earnings Per Share is expected to grow by 3.36% on average over the next years.
Based on estimates for the next years, 1BAYN will show a small growth in Revenue. The Revenue will grow by 1.49% on average per year.
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.36%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.49%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
1BAYN is valuated cheaply with a Price/Earnings ratio of 5.55.
98.15% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 25.46. 1BAYN is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 5.60, which indicates a rather cheap valuation of 1BAYN.
96.30% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 35.39. 1BAYN is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.55 | ||
| Fwd PE | 5.6 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1BAYN is valued cheaper than 81.48% of the companies in the same industry.
100.00% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.84 | ||
| EV/EBITDA | 8.88 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
5. Dividend
5.1 Amount
1BAYN has a yearly dividend return of 0.37%, which is pretty low.
1BAYN's Dividend Yield is slightly below the industry average, which is at 3.01.
Compared to an average S&P500 Dividend Yield of 2.44, 1BAYN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.37% |
5.2 History
The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
The earnings of 1BAYN are negative and hence is the payout ratio. 1BAYN will probably not be able to sustain this dividend level.
DP-3.69%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
BIT:1BAYN (11/18/2025, 7:00:00 PM)
27.285
-0.64 (-2.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners48.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.81B
Revenue(TTM)46.61B
Net Income(TTM)-3.42B
Analysts71.43
Price Target29.23 (7.13%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.37% |
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-3.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)23.87%
Min EPS beat(2)1.86%
Max EPS beat(2)45.89%
EPS beat(4)3
Avg EPS beat(4)8.47%
Min EPS beat(4)-17.26%
Max EPS beat(4)45.89%
EPS beat(8)6
Avg EPS beat(8)3.46%
EPS beat(12)8
Avg EPS beat(12)1.61%
EPS beat(16)12
Avg EPS beat(16)4.59%
Revenue beat(2)0
Avg Revenue beat(2)-1.8%
Min Revenue beat(2)-2.63%
Max Revenue beat(2)-0.98%
Revenue beat(4)1
Avg Revenue beat(4)-1.31%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-1.92%
Revenue beat(12)3
Avg Revenue beat(12)-2.37%
Revenue beat(16)7
Avg Revenue beat(16)-1.04%
PT rev (1m)1.03%
PT rev (3m)1.13%
EPS NQ rev (1m)0.08%
EPS NQ rev (3m)-8.54%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)2.35%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)-0.19%
Revenue NY rev (3m)-0.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.55 | ||
| Fwd PE | 5.6 | ||
| P/S | 0.58 | ||
| P/FCF | 5.84 | ||
| P/OCF | 3.75 | ||
| P/B | 0.88 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.88 |
EPS(TTM)4.92
EY18.03%
EPS(NY)4.87
Fwd EY17.86%
FCF(TTM)4.67
FCFY17.13%
OCF(TTM)7.28
OCFY26.67%
SpS47
BVpS30.91
TBVpS-18.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number58.5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.25% | ||
| ROE | -11.25% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 54.95% | ||
| FCFM | 9.94% |
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score4
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.04 | ||
| Debt/FCF | 8.37 | ||
| Debt/EBITDA | 4.79 | ||
| Cap/Depr | 32.07% | ||
| Cap/Sales | 5.54% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 107.94% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 0.78 |
F-Score4
WACC6.74%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.95%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-38.78%
EPS Next Y-6.5%
EPS Next 2Y-1.77%
EPS Next 3Y1.82%
EPS Next 5Y3.36%
Revenue 1Y (TTM)-2.16%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-2.09%
Revenue Next Year-1.37%
Revenue Next 2Y-0.26%
Revenue Next 3Y0.57%
Revenue Next 5Y1.49%
EBIT growth 1Y-161.08%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.33%
EBIT Next 3Y21.52%
EBIT Next 5Y11.12%
FCF growth 1Y1068.78%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y169.98%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%
BAYER AG-REG / 1BAYN.MI FAQ
What is the fundamental rating for 1BAYN stock?
ChartMill assigns a fundamental rating of 3 / 10 to 1BAYN.MI.
What is the valuation status for 1BAYN stock?
ChartMill assigns a valuation rating of 7 / 10 to BAYER AG-REG (1BAYN.MI). This can be considered as Undervalued.
Can you provide the profitability details for BAYER AG-REG?
BAYER AG-REG (1BAYN.MI) has a profitability rating of 2 / 10.
What is the earnings growth outlook for BAYER AG-REG?
The Earnings per Share (EPS) of BAYER AG-REG (1BAYN.MI) is expected to decline by -6.5% in the next year.
Is the dividend of BAYER AG-REG sustainable?
The dividend rating of BAYER AG-REG (1BAYN.MI) is 0 / 10 and the dividend payout ratio is -3.69%.